We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The faecal immunochemical test (FIT) is commonly used to screen for colorectal cancer but it has low sensitivity (around 50%) for early cancer detection and fails to detect polyps.
Blackstone’s private equity funds have signed a definitive agreement to acquire Japan-based anti-rheumatism drugs manufacturer Ayumi Pharmaceutical from Unison Capital and M3.